4 results match your criteria: "Department of Surgery Duke University Medical Center Durham NC.[Affiliation]"

Article Synopsis
  • Transcatheter edge-to-edge repair (TEER) is a less invasive option for treating mitral regurgitation but carries higher long-term mortality and reintervention risks compared to surgery.
  • A survey of 201 patients showed a clear preference for TEER over surgery, even if it meant accepting greater risks of reintervention and hospitalizations.
  • For patients to prefer surgery over TEER, they would require significant functional improvement, equivalent to moving from class III to class I of the New York Heart Association classification over 5 years.
View Article and Find Full Text PDF

Background Many hospitalized patients are not administered prescribed doses of pharmacologic venous thromboembolism prophylaxis. Methods and Results In this cluster-randomized controlled trial, all adult non-intensive care units (10 medical, 6 surgical) in 1 academic hospital were randomized to either a real-time, electronic alert-triggered, patient-centered education bundle intervention or nurse feedback intervention to evaluate their effectiveness for reducing nonadministration of venous thromboembolism prophylaxis. Primary outcome was the proportion of nonadministered doses of prescribed pharmacologic prophylaxis.

View Article and Find Full Text PDF

Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.

Liver Transpl

May 2021

School of Medicine and Division of Gastroenterology and Hepatology Stanford University Stanford CA Division of Gastroenterology and Hepatology Stanford University School of Medicine Stanford CA Department of Medicine Stanford University Stanford CA Department of Surgery, Multi-Organ Transplantation Stanford University School of Medicine Stanford CA Dumont-UCLA (University of California, Los Angeles) Transplant and Liver Cancer Centers, Department of Surgery David Geffen School of Medicine at UCLA Los Angeles CA Recanati/Miller Transplantation Institute Mount Sinai Medical Center New York NY Annette C. and Harold C. Simmons Transplant Institute Baylor University Medical Center Dallas TX Department of Surgery, Division of Intra-Abdominal Transplantation Loyola University of Chicago, Stritch School of Medicine Maywood IL Department of Transplantation Mayo Clinic Jacksonville FL Division of Gastroenterology and Hepatology Penn Transplant InstituteUniversity of Pennsylvania Philadelphia PA Center for Liver Disease and Transplantation Columbia University Medical Center, NY Presbyterian Hospital New York NY Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery Weill Cornell Medical College New York NY Thomas E. Starzl Transplantation Institute University of Pittsburgh Medical Center Pittsburgh PA Section of TransplantationDepartment of Surgery Washington University in St. Louis St. Louis MO Cleveland Clinic Foundation Cleveland OH Division of Transplant SurgeryDepartment of Surgery University of Colorado School of Medicine Denver CO Division of Transplant Surgery Massachusetts General HospitalHarvard Medical School Boston MA Sherrie & Alan Conover Center for Liver Disease & Transplantation Houston Methodist Hospital Houston TX Department of Surgery University of Nebraska Medical Center Omaha NE Division of Transplantation and Hepatobiliary SurgeryDepartment of Surgery University of California, San Diego San Diego CA Department of Surgery Duke University Medical Center Durham NC Division of Transplant SurgeryDepartment of Surgery Medical College of Wisconsin Milwaukee WI Department of Surgery Baylor College of Medicine Houston TX Section of Hepatobiliary and Transplant Surgery University of Louisville School of Medicine Louisville KY Medstar Georgetown Transplant Institute Georgetown University Washington DC.

The incidence of hepatocellular carcinoma (HCC) is growing in the United States, especially among the elderly. Older patients are increasingly receiving transplants as a result of HCC, but the impact of advancing age on long-term posttransplant outcomes is not clear. To study this, we used data from the US Multicenter HCC Transplant Consortium of 4980 patients.

View Article and Find Full Text PDF